Clinical Trial Update: Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the metabolic effects of pioglitazone in type 2 diabetes patients previously treated with insulin has completed. The update provides res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: IKFE Institute for Clinical Research and Development | Conditions: Type 2 Diabetes Mellitus, Insulin Resistance | Phase 4 | Status: COMPLETED